Study guide

Respiratory failure, ARDS and sepsis

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Respiratory failure, ARDS and sepsis

Key Takeaways Explain This Topic AI

qSOFA is not a stand-alone screening test to exclude sepsis.

Give urgent antimicrobials for septic shock or highly likely sepsis.

Fluid resuscitation needs repeated assessment of response and overload risk.

Last updated: October 2026

Pathophysiology of Acute Respiratory Failure

Respiratory failure occurs when the respiratory system cannot adequately perform gas exchange, resulting in arterial hypoxaemia, carbon dioxide retention, or both. Categorisation into Type 1 and Type 2 guides diagnostic investigation and determines ventilatory support modalities.

Type 1: Hypoxaemic Respiratory Failure

Type 1 respiratory failure is defined by arterial hypoxaemia with a PaO 2 < 60 mmHg \text{PaO}_2 < 60\text{ mmHg} PaO 2 ​ < 60 mmHg ( 8.0 kPa 8.0\text{ kPa} 8.0 kPa ) while breathing room air, accompanied by a normal or low arterial PaCO 2 \text{PaCO}_2 PaCO 2 ​ ( < 45 mmHg < 45\text{ mmHg} < 45 mmHg ) . Hyperventilation in response to hypoxia frequently lowers the PaCO 2 \text{PaCO}_2 PaCO 2 ​ .

Mechanisms:

Ventilation-Perfusion (V/Q) Mismatch: The most common clinical mechanism. Areas of low ventilation relative to perfusion (e.g., bronchospasm, mucous plugging, mild pulmonary oedema) result in desaturated blood leaving pulmonary capillaries. Hypoxaemia from V/Q mismatch responds readily to modest increases in inspired oxygen concentration ( FiO 2 \text{FiO}_2 FiO 2 ​ ).

Right-to-Left Intrapulmonary Shunt: Blood traverses non-ventilated alveolar units without participating in gas exchange (e.g., severe ARDS, dense lobar consolidation, complete lung atelectasis). Shunt fractions exceeding 20% to 30% are refractory to high FiO 2 \text{FiO}_2 FiO 2 ​ alone and require positive end-expiratory pressure (PEEP) to recruit collapsed alveoli.

Diffusion Impairment: Thickened alveolar-capillary membrane (e.g., pulmonary fibrosis) impairs oxygen transit during states of high cardiac output.

Type 2: Hypercapnic Respiratory Failure

Hypercapnic respiratory failure: PaCO2 above the normal range (commonly above 45 mmHg) signifies inadequate alveolar ventilation. Interpret pH and bicarbonate to distinguish acute from chronic disease. Hypoxaemia can coexist, but may be masked by supplemental oxygen. P A O 2 = FiO 2 × ( P atm − P H 2 O ) − PaCO 2 R \text{P}_A\text{O}_2 = \text{FiO}_2 \times (\text{P}_{\text{atm}} - \text{P}_{\text{H}_2\text{O}}) - \frac{\text{PaCO}_2}{\text{R}} P A ​ O 2 ​ = FiO 2 ​ × ( P atm ​ − P H 2 ​ O ​ ) − R PaCO 2 ​ ​

Mechanisms: The fundamental defect is alveolar hypoventilation , reflecting failure of the respiratory 'pump' rather than alveolar parenchymal exchange.

Depressed Central Respiratory Drive: Drug overdoses (opioids, benzodiazepines), brainstem infarcts, severe hypothyroidism, obesity hypoventilation syndrome.

Neuromuscular Weakness: Guillain-Barré syndrome, myasthenia gravis crisis, motor neurone disease, cervical cord injury, severe hypophosphataemia.

Chest Wall & Pleural Deformities: Flail chest, severe kyphoscoliosis, massive ascites, circumferential thoracic burns.

Increased Work of Breathing & Fatigued Muscles: Advanced COPD, status asthmaticus, severe upper airway obstruction.

Arterial PaO 2 \text{PaO}_2 PaO 2 ​ : Type 1 (Hypoxaemic): < 60 mmHg < 60\text{ mmHg} < 60 mmHg ( < 8.0 kPa < 8.0\text{ kPa} < 8.0 kPa ); Type 2 (Hypercapnic): Decreased (unless supplemental O 2 \text{O}_2 O 2 ​ given)

Arterial PaCO 2 \text{PaCO}_2 PaCO 2 ​ : Type 1 (Hypoxaemic): Normal or low ( < 45 mmHg < 45\text{ mmHg} < 45 mmHg ); Type 2 (Hypercapnic): > 50 mmHg > 50\text{ mmHg} > 50 mmHg ( > 6.7 kPa > 6.7\text{ kPa} > 6.7 kPa )

Alveolar-Arterial (A-a) Gradient : Type 1 (Hypoxaemic): Elevated ( > 15 − 20 mmHg > 15-20\text{ mmHg} > 15 − 20 mmHg ); Type 2 (Hypercapnic): Normal if pure hypoventilation; elevated if combined lung disease

Primary Pathology : Type 1 (Hypoxaemic): Alveolar filling, collapse, or vascular occlusion; Type 2 (Hypercapnic): Failure of neuromuscular pump or severe ventilatory dead space

Initial Ventilatory Strategy : Type 1 (Hypoxaemic): High-flow nasal cannula (HFNC) or CPAP; Type 2 (Hypercapnic): Non-invasive ventilation (BiPAP) or mechanical ventilation

Acute Respiratory Distress Syndrome (ARDS)

ARDS is a devastating inflammatory syndrome characterized by diffuse alveolar-capillary endothelial and epithelial barrier disruption, accumulation of proteinaceous alveolar exudate, loss of surfactant, alveolar flooding, and microvascular thrombosis.

The Berlin Definition (a widely used classification; newer global criteria also recognise additional settings) of ARDS

The Berlin criteria mandate four core clinical components:

Timing: Acute onset within 1 week of a known clinical insult (e.g., sepsis, pneumonia, aspiration, major trauma, pancreatitis) or new/worsening respiratory symptoms.

Chest Radiography: Bilateral opacities on chest X-ray or CT scan not fully explained by pleural effusions, lobar/lung collapse, or nodules.

Origin of Oedema: Respiratory failure not fully explained by cardiac failure or hydrostatic fluid overload. Objective assessment (such as echocardiography) is required to exclude hydrostatic pulmonary oedema if no clear risk factor is present.

Oxygenation Impairment: Assessed with a minimum PEEP of ≥ 5 cmH 2 O \ge 5\text{ cmH}_2\text{O} ≥ 5 cmH 2 ​ O :

Mild ARDS: 200 < PaO 2 / FiO 2 ≤ 300 mmHg 200 < \text{PaO}_2/\text{FiO}_2 \le 300\text{ mmHg} 200 < PaO 2 ​ / FiO 2 ​ ≤ 300 mmHg

Moderate ARDS: 100 < PaO 2 / FiO 2 ≤ 200 mmHg 100 < \text{PaO}_2/\text{FiO}_2 \le 200\text{ mmHg} 100 < PaO 2 ​ / FiO 2 ​ ≤ 200 mmHg

Severe ARDS: PaO 2 / FiO 2 ≤ 100 mmHg \text{PaO}_2/\text{FiO}_2 \le 100\text{ mmHg} PaO 2 ​ / FiO 2 ​ ≤ 100 mmHg

Evidence-Based Mechanical Ventilation Strategy

Low Tidal Volume Ventilation: Set tidal volumes at 6 mL/kg 6\text{ mL/kg} 6 mL/kg of Predicted Body Weight (PBW) (calculated from sex and height, never actual weight). Ventilating with standard 10 − 12 mL/kg 10-12\text{ mL/kg} 10 − 12 mL/kg tidal volumes causes severe volutrauma and biotrauma in non-aerated 'baby lungs'.

Plateau Pressure Limitation: Keep end-inspiratory plateau pressure ( P plat P_{\text{plat}} P plat ​ ) ≤ 30 cmH 2 O \le 30\text{ cmH}_2\text{O} ≤ 30 cmH 2 ​ O .

Prone Positioning: For patients with PaO 2 / FiO 2 < 150 mmHg \text{PaO}_2/\text{FiO}_2 < 150\text{ mmHg} PaO 2 ​ / FiO 2 ​ < 150 mmHg , early prone positioning for at least 16 consecutive hours per day significantly reduces 28-day and 90-day mortality. Proning redistributes transpulmonary pressures, unloads the heart, recruits dorsal dependent lung units, and dramatically improves V/Q matching.

Sepsis-3 Definitions & Shock Syndromes

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.

Sepsis-3 Clinical Diagnostic Criteria

Organ Dysfunction: An acute change in total Sequential Organ Failure Assessment (SOFA) score of ≥ 2 \ge 2 ≥ 2 points attributable to the infection. A SOFA increase of 2 reflects an overall in-hospital mortality excess of > 10 % > 10\% > 10% .

qSOFA: A bedside prognostic prompt using respiratory rate, systolic pressure and mental state. It must not be the only sepsis screen; infection plus organ dysfunction, early-warning systems and the overall clinical course guide recognition. Its three components are:

  • Respiratory rate ≥ 22 breaths/min \ge 22\text{ breaths/min} ≥ 22 breaths/min
  • Altered mentation (Glasgow Coma Scale < 15 < 15 < 15 )
  • Systolic blood pressure ≤ 100 mmHg \le 100\text{ mmHg} ≤ 100 mmHg

Septic Shock Definition: A subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality ( > 40 % > 40\% > 40% ). Clinically identified by:

Persistent arterial hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg \ge 65\text{ mmHg} ≥ 65 mmHg , AND

Serum lactate > 2.0 mmol/L > 2.0\text{ mmol/L} > 2.0 mmol/L ( 18 mg/dL 18\text{ mg/dL} 18 mg/dL ) despite adequate intravenous fluid resuscitation.

Differentiating Shock Etiologies

Distributive (Septic / Anaphylactic) : Primary Mechanism: Vasoplegia, peripheral pooling, capillary leak; CVP / PCWP: Decreased or Normal; Cardiac Output: Increased (Early hyperdynamic); Systemic Vascular Resistance (SVR): Markedly Decreased ; Mixed Venous S vO 2 S\text{vO}_2 S vO 2 ​ : Increased ( > 70 % > 70\% > 70% )

Cardiogenic (MI / Arrhythmia) : Primary Mechanism: Primary myocardial pump failure; CVP / PCWP: Increased ; Cardiac Output: Markedly Decreased ; Systemic Vascular Resistance (SVR): Increased (Compensatory); Mixed Venous S vO 2 S\text{vO}_2 S vO 2 ​ : Decreased ( < 60 % < 60\% < 60% )

Hypovolaemic (Haemorrhage) : Primary Mechanism: Loss of intravascular volume; CVP / PCWP: Markedly Decreased ; Cardiac Output: Decreased ; Systemic Vascular Resistance (SVR): Increased (Compensatory); Mixed Venous S vO 2 S\text{vO}_2 S vO 2 ​ : Decreased ( < 60 % < 60\% < 60% )

Obstructive (Massive PE / Tamponade) : Primary Mechanism: Extracardiac outflow obstruction; CVP / PCWP: Increased ; Cardiac Output: Markedly Decreased ; Systemic Vascular Resistance (SVR): Increased (Compensatory); Mixed Venous S vO 2 S\text{vO}_2 S vO 2 ​ : Decreased ( < 60 % < 60\% < 60% )

Septic Shock Resuscitation Bundle

Septic shock requires immediate resuscitation, antibiotics and source control. Possible sepsis without shock warrants rapid assessment rather than treating every infection with an identical compulsory bundle.

Lactate: Follow trends together with capillary refill, mental state, urine output and haemodynamics. Lactate has causes beyond hypoperfusion; a fixed 20% reduction every two hours is not a universal treatment endpoint.

Blood Cultures Prior to Antibiotics: Draw at least two sets of blood cultures (aerobic and anaerobic) before initiating antimicrobials, provided this does not cause significant delay ( > 45 minutes > 45\text{ minutes} > 45 minutes ).

Antibiotics: Give immediately, ideally within one hour, in shock or high-likelihood sepsis. Possible sepsis without shock permits rapid assessment, with treatment within three hours if concern persists. Obtain cultures first only if this does not meaningfully delay urgent treatment.

Sepsis fluids: Give isotonic crystalloid for hypoperfusion in measured boluses with repeated assessment of circulation and fluid responsiveness. The international suggestion of at least 30 mL/kg in the first 3 hours is weak guidance for sepsis-induced hypoperfusion or shock, not a compulsory dose for every infection. Heart failure, renal disease and respiratory deterioration demand adjustment and early vasopressor assessment.

First-Line Vasopressor - Noradrenaline: If mean arterial pressure remains < 65 mmHg < 65\text{ mmHg} < 65 mmHg despite fluid loading, or if the patient presents with profound hypotension, initiate noradrenaline (norepinephrine) immediately via central line (or temporarily via dedicated large-bore peripheral line). Noradrenaline provides potent alpha-1 vasoconstriction with modest beta-1 chronotropy, restoring perfusion pressure without inducing excessive tachycardia.

Second-Line / Refractory Vasopressors: Add vasopressin ( 0.03 units/min 0.03\text{ units/min} 0.03 units/min ) to reduce noradrenaline dosage. For patients with refractory septic shock despite escalating vasopressors, administer intravenous hydrocortisone ( 200 mg/day 200\text{ mg/day} 200 mg/day continuous infusion or 50 mg 50\text{ mg} 50 mg 6-hourly).

Primary references (checked 7 October 2026): Surviving Sepsis Campaign .